These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. Review of management and outcome in 65 patients with lentigo maligna. Al-Niaimi F; Jury CS; McLaughlin S; Herd RM Br J Dermatol; 2009 Jan; 160(1):211-3. PubMed ID: 19014402 [No Abstract] [Full Text] [Related]
34. Development of a Pigmented Facial Lesion Scale Based on Darkness and Extent of Lesions in Older Veterans. Means AD; Lee KC; Korgavkar K; Swetter SM; Dellavalle RP; Chen S; Stricklin G; Weinstock MA; J Invest Dermatol; 2019 May; 139(5):1185-1187. PubMed ID: 30508548 [No Abstract] [Full Text] [Related]
35. [Lentigo maligna: a special melanoma]. Le Gal FA; Toutous-Trellu L; Kaya G; Salomon D Rev Med Suisse; 2011 Apr; 7(289):765-6, 768-71. PubMed ID: 21568099 [TBL] [Abstract][Full Text] [Related]
36. Bedside diagnosis of lentigo maligna with reflectance confocal microscopy. Zubair R; Haroon A; Rao B J Cutan Pathol; 2018 Jul; 45(7):553-555. PubMed ID: 29693252 [No Abstract] [Full Text] [Related]
37. Lentigo maligna in a patient with xeroderma pigmentosum, variant type: A case report with dermoscopic findings and review of the literature. Bang E; Kim YE; Ko JM; Kim MJ; Park SS; Seong MW; Mun JH Photodermatol Photoimmunol Photomed; 2020 Sep; 36(5):401-404. PubMed ID: 32379927 [No Abstract] [Full Text] [Related]
39. An unusual early onset of lentigo maligna in the fourth decade of life. Platsidaki E; Kostopoulos N; Gesakis K; Polydorou D; Agiasofitou E Indian J Dermatol Venereol Leprol; 2019; 85(1):129. PubMed ID: 29327697 [No Abstract] [Full Text] [Related]
40. Validation of a patient decision aid for the treatment of lentigo maligna. Vaidya TS; Bander TS; Musthaq S; Lampley N; Lee EH; Nehal KS; Rossi AM J Am Acad Dermatol; 2021 Jun; 84(6):1751-1753. PubMed ID: 33470203 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]